Jump to content

Draft:Recursion Pharmaceuticals

From Wikipedia, the free encyclopedia

Recursion Pharmaceuticals is a clinical-stage biotechnology company that focuses on mapping and decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering.[1][2]

The company is based in Salt Lake City, Utah. It was founded by Chris Gibson, Dean Li and Blake Borgeson.[3][4]

History

[edit]

In January 2014, the company moved its operations from Dean Li’s lab at the University of Utah to its first facility, and later into the University of Utah Research Park.[5][6] In 2018 Recursion moved into its current location at the Gateway downtown.[7][8] Recursion maintains this facility as well as a satellite office within London, San Francisco Bay Area, Mila (research institute), Toronto and the Quebec Artificial Intelligence Institute, in Montreal.[9][10]

Financials

[edit]

By 2015, Recursion had closed its Series A round of funding and signed a research agreement with Sanofi Genzyme.[11] In 2020, the company received $50 million equity investment from Bayer during its Series D funding round.[12][13]

The company listed on the Nasdaq Stock Exchange on April 20, 2021 under the ticker symbol RXRX.[14][15] In November 2021, Recursion signed a $12B partnership deal with Roche and its subsidiary Genentech to advance therapies in neuroscience among other things.[16][17][18]

References

[edit]
  1. ^ Cornall, Jim (2022-09-14). "Recursion adds FAP and C. diff clinical trials". Labiotech.eu. Retrieved 2024-07-29.
  2. ^ "Recursion Pharma".
  3. ^ Gibson, Chris (2023-07-20). "How Chris Gibson founded Recursion Pharmaceuticals". Utah Business. Retrieved 2024-07-29.
  4. ^ "Board of Directors - Recursion".
  5. ^ "Technology Licensing Office at the University of Utah - Startup news: The latest out of Recursion and Salarius Pharmaceuticals". technologylicensing.utah.edu. Retrieved 2024-07-29.
  6. ^ "Utah AI/biotech innovator Recursion Pharmaceuticals on a roll, doubling downtown HQ". Deseret News. 2023-12-20. Retrieved 2024-07-29.
  7. ^ "Salt Lake mayoral candidate Erin Mendenhall outlines plans for creating a tech ecosystem in the capital city". The Salt Lake Tribune. Retrieved 2024-07-29.
  8. ^ "Recursion Pharma takes high-tech approach to drug discovery". Deseret News. 2023-12-22. Retrieved 2024-07-29.
  9. ^ "Recursion Announces Multi-Year Collaboration with Mila for Tech-Enabled Drug Discovery | Mila". mila.quebec. Retrieved 2024-07-29.
  10. ^ PhD, Andrii Buvailo (2024-03-11). "Recursion Expands Its Presence with a New London Office and Bolsters Scientific Advisory Team". www.biopharmatrend.com. Retrieved 2024-07-29.
  11. ^ Eugene (2016-04-26). "Sanofi's Genzyme, Recursion Partner in Drug Repurposing". DCAT Value Chain Insights. Retrieved 2024-07-29.
  12. ^ Rosenbaum, Leah. "Recursion Pharmaceuticals Raises $239 Million And Partners With Bayer For AI Drug Discovery". Forbes. Retrieved 2024-07-29.
  13. ^ "FirstWord". firstwordpharma.com. Retrieved 2024-07-29.
  14. ^ Carchidi, Alex (2024-04-17). "Where Will Recursion Pharmaceuticals Be in 5 Years?". The Motley Fool. Retrieved 2024-07-29.
  15. ^ "Recursion Pharmaceuticals Inc, RXRX:NSQ summary - FT.com". markets.ft.com. Retrieved 2024-07-29.
  16. ^ Staff, G. E. N. (2021-12-07). "Roche, Genentech, Recursion Launch Up-to-$12B AI Drug Discovery Effort". GEN - Genetic Engineering and Biotechnology News. Retrieved 2024-07-29.
  17. ^ "The moment we worked together to push boundaries in drug discovery". www.celebratelife.roche.com. Retrieved 2024-07-29.
  18. ^ "Roche Signs Machine-Learning Neuroscience Deal With Recursion". Bloomberg.com. 2021-12-07. Retrieved 2024-07-29.


Category:Biotechnology companies of the United States Category:Companies based in South Salt Lake City, Utah Category:Life sciences industry Category:Pharmaceutical companies of the United States Category:Salt Lake City, Utah Category:University spin-offs